Oral delivery of imatinib through galactosylated polymeric nanoparticles to explore the contribution of a saccharide ligand to absorption.
Int J Pharm
; 568: 118508, 2019 Sep 10.
Article
in En
| MEDLINE
| ID: mdl-31299337
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Carriers
/
Protein Kinase Inhibitors
/
Nanoparticles
/
Imatinib Mesylate
/
Polylactic Acid-Polyglycolic Acid Copolymer
/
Galactose
/
Antineoplastic Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
Int J Pharm
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: